IDEX Corporation acquired Isolation Technologies, a transaction completed in October 2007, structured as all cash (asset acquisition). The deal was a Asset purchase.
Isolation Technologies operates in Health & Science Technologies, is based in Hopedale, Massachusetts, USA, had revenue of about approximately $12 million annual revenue. Leading developer of advanced column hardware and accessories for the High Performance Liquid Chromatography (HPLC) market; used in drug discovery and quality control for pharmaceutical and food/beverage testing. Headquartered in Hopedale, Massachusetts.
HST Core reporting unit within the Health and Science Technologies segment
On October 18, 2007, the Company acquired the assets of Isolation Technologies, a leading developer of advanced column hardware and accessories for the High Performance Liquid Chromatography (HPLC) market.
Advisory firms were not disclosed for this transaction.